丹麦新诺迪斯克制药商建立了全球招聘冻结制度,面临市场价值下降和新的领导地位。 Danish drugmaker Novo Nordisk institutes global hiring freeze, facing market value drop and new leadership.

丹麦新诺迪斯克制药商对全球非关键角色的雇用实行全球冻结,影响到所有市场和部门。 Danish drugmaker Novo Nordisk has put a global hiring freeze in place for non-critical roles, affecting all markets and departments. 由于利润警告,公司市场价值在7月下跌700亿美元之后,才采取了这一行动。 The move comes after the company's market value dropped by $70 billion in July due to a profit warning. 8月开始的新CEOMike Doustdar正在研究削减成本的措施, 包括潜在的裁员, 因为Novo Nordisk面临来自Eli Lilly等竞争对手的竞争日益激烈。 New CEO Mike Doustdar, who started in August, is looking into cost-cutting measures, including potential layoffs, as Novo Nordisk faces increased competition from rivals like Eli Lilly.